Latest stories on PALI
Palisade Bio Advances ASCENTRA-UC Trial, PALI-2108 Moves Deeper Into Ulcerative Colitis Market
TipRanks58 · neutralproduct/pr
Oppenheimer reiterates Palisade Bio stock rating on Crohn’s data
Investing.com Analyst Ratings52 · neutralanalyst
Palisade Bio presents clinical, translational findings at UEG
The Fly58 · neutralproduct/pr
Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026
Business Insider64 · neutralproduct/pr
H.C. Wainwright reiterates Palisade Bio stock rating at buy
Investing.com Analyst Ratings58 · neutralanalyst
Palisade Bio stock initiated at Outperform by Raymond James
Investing.com Analyst Ratings63 · neutralanalyst
Palisade Bio initiated with an Outperform at Raymond James
The Fly63 · neutralanalyst
Palisade Bio to present clinical, translational data for PALI-2108 at UEG Week
The Fly63 · neutralproduct/pr
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
Business Insider63 · neutralproduct/pr
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
GlobeNewswire63 · neutralproduct/pr
Palisade Bio expands Phase 2b Ascentra-UC with Health Canada CTA clearance
The Fly63 · neutralproduct/pr
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
GlobeNewswire67 · bullishproduct/pr
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
Business Insider67 · bullishproduct/pr
Palisade Bio receives FDA clearance of IND for PALI-2108
The Fly65 · bullishproduct/pr
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
GlobeNewswire67 · bullishproduct/pr
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
Business Insider67 · bullishproduct/pr
Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
StockTitan56 · neutralgeneral
Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire56 · neutralgeneral
Palisade Bio, Inc. (PALI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Palisade Bio to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Palisade Bio to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral